FENC - Company ID 0001211583
The table below shows FENNEC PHARMACEUTICALS INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$12.47M | $26.98M | -$17.14M | -$18.06M | -$14.22M | -$15.60M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | - | - | - | - | - | - |
| Dividends paid | - | - | - | - | - | - |
FENNEC PHARMACEUTICALS INC. reported operating cash flow of -$12.47M for fiscal year 2025. That is down 146.2% from $26.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$2.12M (FY 2016) to -$12.47M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks |
| - |
| - |
| - |
| - |
| - |
| - |
| Financing cash flow | $22.63M | -$13.62M | $6.64M | $20.73M | $4.98M | $32.29M |